Filing Details
- Accession Number:
- 0001104659-18-042165
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-06-26 09:09:23
- Reporting Period:
- 2018-06-23
- Accepted Time:
- 2018-06-26 09:09:23
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1641640 | Nabriva Therapeutics Plc | NBRV | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1693064 | P. Steven Gelone | 1000 Continental Drive Suite 600 King Of Prussia PA 19406 | Chief Scientific Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Acquisiton | 2018-06-23 | 10,000 | $3.82 | 22,740 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
